Daiichi Sankyo completes enrolment in Hokusai-VTE clinical study
Hokusai-VTE Phase 3 study, which enrolled more than 8,250 patients from more than 400 clinical sites, will compare Edoxaban 60mg once-daily to warfarin control therapy. The double-dummy, event-driven,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.